Search results for "respirator"

showing 10 items of 5336 documents

Removal of silicon from CFB-derived fly ash leachate in the context of phosphorus recovery

2018

High concentrations of dissolved silica in the acid leachate impose two major challenges on precipitation based recovery of phosphorus (P). Firstly, co-precipitation of colloidal silica in the acidic regimes decreases the purity and value of precipitated P-products. In addition, silica scaling on internal surfaces of equipment is also a problematic issue in industrial operations. Therefore, removal of dissolved silica prior to P-recovery process minimizes the risks of Si-contamination in P-products and Si-scaling. In the present study, silica removal was achieved by accelerated silica polymerization with higher acidity and ionic strength of mineral acid, which also assisted the leaching of …

piiDissolved silicaSiliconColloidal silicachemistry.chemical_element02 engineering and technologyIndustrial and Manufacturing Engineeringphosphorus recyclesilica polymerization020401 chemical engineeringMaterials ChemistrylentotuhkaLeachate0204 chemical engineeringta116ta215fosforichemistry.chemical_classificationChemistryMetals and AlloysMineral acidrespiratory system021001 nanoscience & nanotechnologyfly ash utilizationtalteenottoChemical engineeringIonic strengthFly ashsilica removalLeaching (metallurgy)0210 nano-technologyHydrometallurgy
researchProduct

Correction to: Bacterial etiology of community-acquired pneumonia in immunocompetent hospitalized patients and appropriateness of empirical treatment…

2021

In the originally published article, the individual collaborator names were not captured under the group name “GLIMP Collaborators”. The names are now captured correctly under this group accordingly. The original article has been corrected.

pneumoniaSettore MED/10 - Malattie Dell'Apparato Respiratorio
researchProduct

Correlazioni radiologico-funzionali nell' inquadramento delle pneumopatie croniche diffuse

2014

pneumopatie croniche diffuseSettore MED/10 - Malattie Dell'Apparato RespiratorioImaging Test funzionali
researchProduct

Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded gucocorticoid after aerosolization in mice

2016

Abstract In this study, novel polymeric nanoparticles (NPs) were developed and their potential as carriers for beclomethasone dipropionate (BDP) into the lung after aerosolization was demonstrated by in vivo studies in mice. In particular, these NPs were obtained starting from two polyaspartamide-based copolymers which were synthesized by chemical reaction of α,β-poly(N-2-hydroxyethyl)- dl -aspartamide (PHEA) and its pegylated derivative (PHEA-PEG2000) with poly(lactic acid) (PLA). To obtain nanosized particles, the high pressure homogenization (HPH)—solvent evaporation method was followed by using an organic phase containing both PHEA-PLA and PHEA-PEG2000-PLA (at a weight ratio equal to 1:…

polymeric nanoparticles beclomethasone dipropionate aerosolization in miceBiodistributionDrug Evaluation PreclinicalPolymeric nanoparticles Beclomethasone dipropionate (BDP) PolyhydroxyethylaspartamidePharmaceutical ScienceNanotechnology02 engineering and technology010402 general chemistry01 natural scienceschemistry.chemical_compoundMicePulmonary surfactantIn vivoPEG ratioAdministration InhalationmedicineAnimalsTissue DistributionGlucocorticoidsLungAerosolizationAerosolsChromatographyLungmedicine.diagnostic_testtechnology industry and agricultureBeclomethasonerespiratory system021001 nanoscience & nanotechnology0104 chemical sciencesLactic acidBronchoalveolar lavagemedicine.anatomical_structurechemistryNanoparticles0210 nano-technologyPeptidesBronchoalveolar Lavage Fluid
researchProduct

TEMPORAL CHANGES IN RESPIRATORY SYMPTOMS/DISEASES AND ASSOCIATED RISK FACTORS IN REAL LIFE

Background: The prevalence of respiratory diseases increased during last centuries and the rapid rise in the prevalence of such diseases cannot be explained by genetic factors. Analyses on general population samples investigated at interval of some years can permit to better comprehend these increases and the associated risk factors, adding new evidences on this important item taking into account the real life setting. Aims: to assess real life temporal changes in respiratory diseases/symptoms (asthma, allergic rhinitis - AR - and chronic obstructive pulmonary disease - COPD) and associated risk factors in general population samples investigated during a period of 30 years. Methods: a gener…

population-based datasmoking habitsrespiratory symptoms/diseaseenvironmental risk factor
researchProduct

Pressure support ventilation + sigh in acute hypoxemic respiratory failure patients: Study protocol for a pilot randomized controlled trial, the PROT…

2018

Background Adding cyclic short sustained inflations (sigh) to assisted ventilation yields optimizes lung recruitment, decreases heterogeneity and reduces inspiratory effort in patients with acute hypoxemic respiratory failure (AHRF). These findings suggest that adding sigh to pressure support ventilation (PSV) might decrease the risk of lung injury, shorten weaning and improve clinical outcomes. Thus, we conceived a pilot trial to test the feasibility of adding sigh to PSV (the PROTECTION study). Methods PROTECTION is an international randomized controlled trial that will be conducted in 23 intensive care units (ICUs). Patients with AHRF who have been intubated from 24 h to 7 days and under…

procedurePressure supportTime Factorsgenetic structuresbreathingmedicine.medical_treatmentMedicine (miscellaneous)Pilot Projects[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tractintensive care unitlaw.inventionPositive-Pressure RespirationStudy Protocol0302 clinical medicineMechanical ventilationRandomized controlled triallawtime factorClinical endpointpatient safetyMulticenter Studies as TopicPharmacology (medical)030212 general & internal medicinerandomized controlled trial (topic)Intervention study; Mechanical ventilation; Positive-pressure ventilation; Pressure support; Recruitment; Sigh; Ventilator-induced lung injury; Weaning; Feasibility Studies; Humans; Hypoxia; Intubation Intratracheal; Lung; Multicenter Studies as Topic; Pilot Projects; Positive-Pressure Respiration; Recovery of Function; Respiratory Insufficiency; Time Factors; Treatment Outcome; Randomized Controlled Trials as Topic; Medicine (miscellaneous); Pharmacology (medical)HypoxiaLungpathophysiologyendotracheal intubationRandomized Controlled Trials as TopicVentilator-induced lung injurylcsh:R5-920Intervention studyadultpilot studyfeasibility studytreatment outcome Feasibility Studie3. Good healthTreatment OutcomeAnesthesiapositive end expiratory pressureBreathingmulticenter study (topic)oxygenationRecruitmentlcsh:Medicine (General)Respiratory Insufficiencyrespiratory tract intubationcirculatory and respiratory physiologyHumanextubationPressure support ventilationWeaningLung injuryArticleSpontaneous breathing trialNO03 medical and health sciencesIntensive care[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicineIntubation IntratrachealHumanscontrolled studyPilot ProjectSightreatment failureMechanical ventilationhypoxemiapressure support ventilationtreatment durationbusiness.industrylung inflationrespiratory failureconvalescenceRecovery of Functionmajor clinical studymortalitywater acute respiratory failurehospital dischargeIntratracheal030228 respiratory systemrandomized controlled trialFeasibility StudiesbusinessPositive-pressure ventilationIntubationclinical protocol
researchProduct

Perception of the Professional Knowledge of and Education on the Medical Technology Products among the Pharmacists in the Baltic and Nordic Countries…

2016

Article

professional competencyMenntunmedicine.medical_specialtyHigher educationLyfjafræðimedia_common.quotation_subjectExploratory researchlcsh:RS1-441Pharmacypracticing pharmacistsPROFESSIONAL COMPETENCEArticlelcsh:Pharmacy and materia medicaLæknisfræði03 medical and health sciences0302 clinical medicineTækniPerceptionHealth careMedicinePharmacology (medical)030212 general & internal medicineGeneral Pharmacology Toxicology and PharmaceuticsCompetence (human resources)media_commonVDP::Social science: 200::Education: 280::Subject didactics: 283Medical educationpharmcy educationeducationbusiness.industryVDP::Medical disciplines: 700::Basic medical dental and veterinary science disciplines: 710::Pharmacology: 7284. EducationHealth technologyCOMPETENCENemendurVDP::Samfunnsvitenskap: 200::Pedagogiske fag: 280::Fagdidaktikk: 283Peer reviewmedical technology; education; pharmacy students; practicing pharmacists; professional competency030228 respiratory systemFagmennska317 Pharmacymedical technologyFamily medicinepharmacy studentspractising pharmacistsVDP::Medisinske Fag: 700::Basale medisinske odontologiske og veterinærmedisinske fag: 710::Farmakologi: 728business
researchProduct

Iedzīvotāju līdzestība respiratoro vīrusu profilaksē

2021

Bakalaura darba tēma “Iedzīvotāju līdzestība respiratoro vīrusu profilaksē”. Darba mērķis: noskaidrot iedzīvotāju līdzestību respiratoro vīrusu profilaksē. Hipotēze: Iedzīvotāji ir līdzestīgi un aktīvi respiratoro vīrusu profilaksē. Bakalaura darbs sastāv no teorētiskās un empīriskās daļas, kā arī 2 pielikumiem. Teorētiskajā daļā analizēta Katrīnas Kolcabas (Katharine Kolcaba) Labsajūtas teorija saistībā ar iedzīvotāju līdzestību respiratoro vīrusu profilaksē, apskatīta literatūra par respiratoro vīrusu raksturojumu, respiratoro vīrusu izplatību ierobežojošajiem profilaktiskajiem pasākumiem, tādiem, kā uzvedība, vakcinācija un imunitātes stiprināšanas iespējas. Pētījumam izvēlēta kvantitatī…

profilakserespiratorie vīrusilīdzestībaizplatību ierobežojošie faktoriMedicīna
researchProduct

An Overview of Asthma and COVID-19: Protective Factors Against SARS-COV-2 in Pediatric Patients.

2021

Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by severe acute respiratory syndrome coronavirus SARS-COV-2. Aberrant innate immunity response and cytokine storm are responsible for the syndrome. Apparently, in asthmatic patients, the inadequate antiviral immune response and the tendency for asthma exacerbation evoked by common respiratory viruses could explain increased susceptibility to SARS-COV-2 infection. However, asthma has not been suggested to be a risk factor in COVID-19 patients. Therefore, in asthmatic patients some potential protective mechanisms against SARS-COV-2 have been hypothesized, like type 2 immune response, number of eosinophils, overproduct…

protective factorMini ReviewProtective factorPediatricsRJ1-570Type 2 immune response03 medical and health sciences0302 clinical medicineImmune systemSettore MED/38 - Pediatria Generale E Specialisticachildrenmedicine030212 general & internal medicineRisk factorAsthmaInnate immune systembusiness.industrySARS-CoV-2COVID-19asthmamedicine.diseaserespiratory tract diseases030228 respiratory systemInfectious disease (medical specialty)ImmunologyPediatrics Perinatology and Child HealthCytokine stormbusinessFrontiers in pediatrics
researchProduct

Remodeling of bronchial and pulmonary muscular arteries in mild/moderate COPD

2014

Pulmonary hypertension is well documented in severe COPD but little is known about vascular remodeling in mild/moderate patients. Aim:To investigate bronchial and pulmonary muscular arteries morphology and the expression of elastic fibers (EF) and collagen I in the lungs of mild/moderate COPD patients. Methods:Lung tissue of 18 COPD subject (FEV1:67±15%pred), 14 non-obstructed smokers(NOS) (FEV1:95±10%pred) and 11 never-smoking controls(CTRL) (FEV1:108±15%pred) was used to analyze the morphology of bronchial and pulmonary muscular arteries and the expression of EF and collagen I in the tunica intima, media and adventitia, using immune- and histochemistry and image analysis. Values (mean±SD)…

pulmonary arteriepulmonary hypertensionCOPDSettore MED/10 - Malattie Dell'Apparato Respiratoriobronchial arterie
researchProduct